- Halozyme won a court order blocking Merck's injected Keytruda in select European markets, Reuters reported.
- Merck is the named manufacturer whose injected Keytruda is blocked; Halozyme is the party that obtained the order.
- The order is limited to select European markets, so it is a regional block rather than a global one.
Quotes
“Halozyme wins court order to block Merck's injected Keytruda in select European markets”